Cediranib CAS:288383-20-0

Cediranib  CAS:288383-20-0
Product Details

Product Information

CAS NO.288383-20-0 1.png
Product NameCediranib
Molecular Weight450.51
Spec / Purity98%min
Supply Capacity
DetailsCediranib (AZD-2171) is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases. On 8 March 2010, AstraZeneca issued a press-release stating that cediranib had failed Phase III clinical trials for use in first-line metastatic colorectal cancer when it was compared clinically with the market-leader bevacizumab. As of November 2012, it was being assessed in double-blind studies for the treatment of methylated Glioblastoma Multiforme at the University of Washington Medical Center.

If you are going to consult the information about cediranib cas:288383-20-0 from one of the leading Bioactive Molecules manufacturers and suppliers in China, It is always at your service.